Published in Diabetes Care on May 01, 1997
Effect of anticipation during unknown or unexpected exercise duration on rating of perceived exertion, affect, and physiological function. Br J Sports Med (2005) 0.93
Interaction between drug and placebo effects: a cross-over balanced placebo design trial. Trials (2010) 0.82
Exploring the performance reserve: Effect of different magnitudes of power output deception on 4,000 m cycling time-trial performance. PLoS One (2017) 0.75
Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes (2006) 2.28
The influence of insulin antibodies on the pharmacokinetics of NPH insulin in patients with type 1 diabetes treated with human insulin. Diabet Med (1995) 1.40
Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes (1997) 1.26
Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients. Diabetologia (2011) 1.25
A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene. Diabet Med (1998) 1.21
Olfactory information processing during the course of the menstrual cycle. Biol Psychol (1996) 1.08
Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans. J Clin Endocrinol Metab (2000) 1.03
The UK Prospective Diabetes Study. Lancet (1998) 0.98
Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors. Br J Ophthalmol (2000) 0.96
Night-time plasma cortisol secretion is associated with specific sleep stages. Biol Psychiatry (1986) 0.93
Differential effects of human and pork insulin-induced hypoglycemia on neuronal functions in humans. Diabetes (1990) 0.91
Multiple complications and frequent severe hypoglycaemia in 'elderly' and 'old' patients with Type 1 diabetes. Diabet Med (2012) 0.91
Excess triiodothyronine as a risk factor of coronary events. Arch Intern Med (2000) 0.90
Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans. J Clin Endocrinol Metab (1999) 0.89
Amperometric biosensor for in vivo glucose sensing based on glucose oxidase immobilized in a redox hydrogel. Biosens Bioelectron (1994) 0.89
On line continuous monitoring of subcutaneous tissue glucose is feasible by combining portable glucosensor with microdialysis. Horm Metab Res (1993) 0.88
Insulin therapy in relation to circulating C-peptide levels. Diabetes (1978) 0.88
Fetal hemoglobin in starvation ketosis of young women. Blood (1998) 0.85
Association between depression and subclinical carotid atherosclerosis in patients with Type 1 diabetes. Diabet Med (2008) 0.85
Glucose concentration in human subcutaneous adipose tissue: comparison between forearm and abdomen. Exp Clin Endocrinol Diabetes (1998) 0.85
The efficacy of a compact psychoeducational group training program for married couples. J Consult Clin Psychol (1998) 0.84
Does insulin play a role in the regulation of its own secretion? Horm Metab Res (1978) 0.83
Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24-hour continuous blood glucose monitoring. Diabetes Care (1985) 0.83
Influences of corticosteroids, dexamethasone and hydrocortisone on sleep in humans. Neuropsychobiology (1986) 0.83
Combination of microdialysis and glucosensor permits continuous (on line) SC glucose monitoring in a patient operated device. II. Evaluation in animals. Horm Metab Res (1992) 0.82
Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell. Horm Metab Res (1976) 0.82
Comparison of the biologic activity of biosynthetic human insulin and natural pork insulin in juvenile-onset diabetic subjects assessed by the glucose controlled insulin infusion system. Diabetes Care (1981) 0.81
Studies on the pathogenesis of the dawn phenomenon in insulin-dependent diabetic patients. Metabolism (1984) 0.80
Human memory and neurohypophyseal hormones: opposite effects of vasopressin and oxytocin. Psychoneuroendocrinology (1984) 0.80
Continuous glucose monitoring reveals associations of glucose levels with QT interval length. Diabetes Technol Ther (2010) 0.80
Relationships between sleep stages and plasma cortisol: a single case study. Acta Endocrinol (Copenh) (1986) 0.79
Classically conditioned changes of blood glucose level in humans. Physiol Behav (1993) 0.78
Association of antidiabetic therapies to glycemic control and to body weight in type 2 diabetes: a German multicenter analysis on 9294 patients. Exp Clin Endocrinol Diabetes (2010) 0.78
Increase in systolic blood pressure and catecholamine level during hyperinsulinemia in a placebo-controlled euglycemic clamp in healthy subjects. Exp Clin Endocrinol Diabetes (2000) 0.78
Preserved counterregulatory hormone release and symptoms after short term hypoglycemic episodes in normal men. J Clin Endocrinol Metab (1995) 0.78
Daily insulin doses and injection frequencies of neutral protamine hagedorn (NPH) insulin, insulin detemir and insulin glargine in type 1 and type 2 diabetes: a multicenter analysis of 51 964 patients from the German/Austrian DPV-wiss database. Diabetes Metab Res Rev (2014) 0.78
[A new test-strip for checking blood-sugar levels]. Dtsch Med Wochenschr (1982) 0.78
Combination of microdialysis and Glucosensor permits continuous (on line) s.c. glucose monitoring in a patient operated device: I. In vitro evaluation. Horm Metab Res (1991) 0.77
Vasopressin and electrophysiological signs of attention in man. Peptides (1986) 0.77
The artificial endocrine pancreas in clinical research. Horm Metab Res (1977) 0.77
Effects of insulin and hypoglycemia on the auditory brain stem response in humans. J Neurophysiol (1994) 0.77
Differential effects of hydrocortisone, fluocortolone, and aldosterone on nocturnal sleep in humans. Acta Endocrinol (Copenh) (1987) 0.77
Modulation of pain perception in man by a vasopressin analogue. Peptides (1996) 0.77
[Postoperative blood-sugar regulation in pancreatectomized patients using the artificial "beta cell"]. Chirurg (1979) 0.77
Is there a benefit to use calculated percent body fat or age- and gender-adjusted BMI-SDS(LMS) to predict risk factors for cardiovascular disease? A German/Austrian multicenter DPV-Wiss analysis on 42 048 type 2 diabetic patients. Exp Clin Endocrinol Diabetes (2013) 0.77
Vasopressin does not enhance memory processes: a study in human twins. Peptides (1985) 0.76
Perioperative management of the diabetic patient. Exp Clin Endocrinol Diabetes (1995) 0.76
Dishabituating effects of an ACTH 4-9 analog in a vigilance task. Pharmacol Biochem Behav (1984) 0.76
Effects of DGAVP on verbal memory. Peptides (1989) 0.76
Memory deficits at 0.6 MPa ambient air pressure. Undersea Hyperb Med (1998) 0.76
Peripheral arterial disease in diabetes mellitus type 1 and type 2: are there different risk factors? Vasa (2002) 0.76
Dose-dependent influences on electrophysiological signs of attention in humans after neuropeptide ACTH 4-10. Exp Brain Res (1987) 0.76
Hormonal responses to exhausting physical exercise: the role of predictability and controllability of the situation. Psychoneuroendocrinology (1990) 0.76
Acute stress modulates symptom awareness and hormonal counterregulation during insulin-induced hypoglycemia in healthy individuals. Int J Behav Med (1998) 0.76
Cortisol effects on attentional processes in man as indicated by event-related potentials. Psychophysiology (1987) 0.76
[Effect of pancreatin on diabetes mellitus in chronic pancreatitis]. Z Gastroenterol (1990) 0.76
An ACTH 4-9 analog impairs selective attention in man. Life Sci (1985) 0.76
[Costs of antihyperglycemic treatment and consumables and treatment satisfaction in patients with type 2 diabetes]. Dtsch Med Wochenschr (2009) 0.75
[Glitazone - mailing no 2. In response to DMW 49/2007]. Dtsch Med Wochenschr (2008) 0.75
Counter-regulatory hormone responses to human and porcine insulin induced hypoglycaemia. Lancet (1990) 0.75
Glucose infusion rates during euglycaemic clamps do not precisely reflect action profiles of subcutaneously injected insulin. Diabetologia (1991) 0.75
Vasopressin and cognitive processes: two event-related potential studies. Peptides (1992) 0.75
[Autonomy of hormone secretion in insulinoma]. Verh Dtsch Ges Inn Med (1978) 0.75
Different effects of human and porcine insulin on hypoglycemia-induced abnormalities of brainstem sensory function. Clin Physiol Biochem (1990) 0.75
Impaired blood pressure response to norepinephrine in a case of insulin-dependent diabetes mellitus--improvement with a beta-adrenergic antagonist. Klin Wochenschr (1984) 0.75
Feedback inhibition of insulin in healthy and overweight subjects studied by use of an artificial endocrine pancreas. Horm Metab Res Suppl (1979) 0.75
Characterization of insulin resistance in type I diabetes. Klin Wochenschr (1985) 0.75
Insulin treatment during diabetic coma with an artificial endocrine pancreas. Horm Metab Res Suppl (1979) 0.75
[Insulin treatment of decompensated diabetes mellitus with a new artificial endocrine pancreas (author's transl)]. Dtsch Med Wochenschr (1977) 0.75
Importance of early postprandial insulin delivery in insulin-dependent diabetics. Klin Wochenschr (1984) 0.75
The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics. Horm Metab Res Suppl (1979) 0.75
Antidiabetic action of somatostatin assessed by artificial beta-cell. Metabolism (1978) 0.75
D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics. Horm Metab Res Suppl (1979) 0.75
Use of artificial pancreas and portable insulin infusion pumps in diabetes therapy: past, present, and future. Artif Organs (1985) 0.75
The influence of a vasopressin-analogue (DGAVP) on event-related potentials in a stimulus-mismatch paradigm. Biol Psychol (1989) 0.75
[Mobile and transportable blood glucose monitors: methodological and technical aspects]. Verh Dtsch Ges Inn Med (1987) 0.75
[The artificial endocrine pancreas and insulin pumps: past, present and future]. Bull Mem Acad R Med Belg (1984) 0.75
Effects of proinsulin on carbohydrate metabolism in diabetes mellitus. N Engl J Med (1987) 0.75
Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics. Horm Metab Res Suppl (1979) 0.75
Abnormal growth hormone levels in insulin-dependent diabetic patients under continuous subcutaneous insulin infusion and intensified conventional treatment. Acta Endocrinol (Copenh) (1984) 0.75
[The Noonan syndrome (author's transl)]. MMW Munch Med Wochenschr (1980) 0.75
The artificial endocrine pancreas: its impact on the pathophysiology and treatment of diabetes mellitus. Diabetes Care (1981) 0.75
A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery. Life Support Syst (1985) 0.75
Nocturnal blood pressure elevation is related to adrenomedullary hyperactivity, but not to hyperinsulinemia, in nonobese normoalbuminuric type 1 diabetes. J Clin Endocrinol Metab (1996) 0.75
Semisynthetic human insulin and purified pork insulin do not differ in their biological potency. Klin Wochenschr (1984) 0.75
[Progress in insulin therapy of diabetes mellitus]. MMW Munch Med Wochenschr (1982) 0.75
Application of an artificial endocrine pancreas in the management of the diabetic surgical patient. Horm Metab Res Suppl (1979) 0.75
[Artificial pancreas: development and significance for the study and management of diabetes]. Verh Dtsch Ges Inn Med (1981) 0.75
In vivo measurement of subcutaneous glucose concentrations with an enzymatic glucose sensor and a wick method. Klin Wochenschr (1989) 0.75
Human C-peptide. Part II: Clinical studies. Klin Wochenschr (1976) 0.75
Substitution of islet cell function by mechanical device: extracorporeal artificial pancreas. Adv Exp Med Biol (1979) 0.75
Alterations in serum concentrations of T4, T3 and r-T3 in normoglycemic glucose clamp-evidence of intercompartmental shifting ? Horm Metab Res (1981) 0.75
["Glucosensor Unitec Ulm". A portable, continuously measuring glucose sensor and monitor]. Biomed Tech (Berl) (1990) 0.75
[Clinical testing of a new blood glucose measuring system. A cooperative study at 8 centers]. Dtsch Med Wochenschr (1987) 0.75
Progress in practical endocrinology. The Glucosensor Unitec Ulm--a portable monitor for continuous blood glucose measurement. Horm Metab Res (1990) 0.75
[New methods of insulin therapy]. Internist (Berl) (1987) 0.75
Analgesic effect of ceruletide in men is limited to specific pain qualities. Physiol Behav (1996) 0.75
Effects of vasopressin on the habituation of the orienting reaction in men. Peptides (1992) 0.75
[C-peptide determination as a parameter for oral diabetes therapy]. Verh Dtsch Ges Inn Med (1976) 0.75